Diabetic Polyneuropathy: New Strategies to Target Sensory Neurons in Dorsal Root Ganglia
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24065977 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Akiko Miyashita und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Neurological Science, Tokyo Medical and Dental University, Tokyo 113-8519, Japan. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Diabetes Mellitus. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Diabetic polyneuropathy (DPN) is the most common type of diabetic neuropathy, rendering a slowly progressive, symmetrical, and length-dependent dying-back axonopathy with preferential sensory involvement. Although the pathogenesis of DPN is complex, this review emphasizes the concept that hyperglycemia and metabolic stressors directly target sensory neurons in the dorsal root ganglia (DRG), leading to distal axonal degeneration. In this context, we discuss the role for DRG-targeting gene delivery, specifically oligonucleotide therapeutics for DPN. Molecules including insulin, GLP-1, PTEN, HSP27, RAGE, CWC22, and DUSP1 that impact neurotrophic signal transduction (for example, phosphatidylinositol-3 kinase/phosphorylated protein kinase B [PI3/pAkt] signaling) and other cellular networks may promote regeneration. Regenerative strategies may be essential in maintaining axon integrity during ongoing degeneration in diabetes mellitus (DM). We discuss specific new findings that relate to sensory neuron function in DM associated with abnormal dynamics of nuclear bodies such as Cajal bodies and nuclear speckles in which mRNA transcription and post-transcriptional processing occur. Manipulating noncoding RNAs such as microRNA and long-noncoding RNA (specifically MALAT1) that regulate gene expression through post-transcriptional modification are interesting avenues to consider in supporting neurons during DM. Finally, we present therapeutic possibilities around the use of a novel DNA/RNA heteroduplex oligonucleotide that provides more efficient gene knockdown in DRG than the single-stranded antisense oligonucleotide.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Neurological Science, Tokyo Medical and Dental University, Tokyo 113-8519, Japan.
- Center for Brain Integration Research, Tokyo Medical and Dental University, Tokyo 113-8519, Japan.
- Department of Neurology, Nissan Tamagawa Hospital, Tokyo 158-0095, Japan.
- Division of Neurology and Department of Medicine, Faculty of Medicine and Dentistry, The Neuroscience and Mental Health Institute and The Alberta Diabetes Institute, University of Alberta, Edmonton, AB T6G 2G3, Canada.
ORCID-Profile: Akiko Miyashita, Masaki Kobayashi
Förderung
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Miyashita, A., Kobayashi, M., Yokota, T., & Zochodne, D. W. (2023). Diabetic Polyneuropathy: New Strategies to Target Sensory Neurons in Dorsal Root Ganglia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065977
Vancouver
Miyashita A, Kobayashi M, Yokota T, Zochodne DW. Diabetic Polyneuropathy: New Strategies to Target Sensory Neurons in Dorsal Root Ganglia. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065977
BibTeX
@article{Miyashita2023,
author = {Miyashita, Akiko and Kobayashi, Masaki and Yokota, Takanori and Zochodne, Douglas W},
title = {Diabetic Polyneuropathy: New Strategies to Target Sensory Neurons in Dorsal Root Ganglia},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24065977}
}
EUVIMED